Market cap
$655 Mln
Revenue (TTM)
$320 Mln
P/E Ratio
--
P/B Ratio
3.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 10.44 | 8.05 | 9.46 | -1.86 | 1.93 |
| EBIT | -36.90 | -200.85 | -49.62 | 5.26 | -0.46 |
| Net Profit | -41.08 | -88.51 | -8.09 | 11.69 | -1.55 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | May-26 | May-25 | May-24 |
| EBIT-Margin
| -8.79 | -7.53 | -7.02 | -8.23 | -11.14 |
| Net Margin
| -- | -11.96 | -- | -- | -- |
| Return on equity
| -33.80 | -24.12 | -20.77 | -17.50 | -63.15 |
| Return on Capital
| -31.16 | -22.18 | -20.19 | -16.85 | -56.45 |
| Return on Assets
| -22.72 | -16.52 | -13.43 | -11.37 | -43.36 |
| Debt to Equity (x)
| -- | -- | -- | 0.06 | 0.02 |
Profitability
ROCE
-20.19
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-20.19
|
-16.85
|
-56.45
|
-11.64
|
-5.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-20.77
--
Profit after tax / Average Net worth * 100
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-20.77
|
-17.50
|
-63.15
|
-13.07
|
-6.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-13.43
--
Profit after tax / Average Total assets * 100
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-13.43
|
-11.37
|
-43.36
|
-9.66
|
-4.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-7.02
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-7.02
|
-8.23
|
-11.14
|
-5.51
|
-5.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-11.48
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-11.48
|
-11.62
|
-60.66
|
-15.51
|
-8.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.09
--
Year on year growth in net sales
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
0.09
|
-0.04
|
-0.10
|
0.07
|
0.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
6.63
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
6.63
|
28.90
|
-81.19
|
-2.54
|
48.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-8.09
--
Year on year growth in profit after tax
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-8.09
|
81.56
|
-251.53
|
-97.54
|
15.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
--
|
0.06
|
0.02
|
0.17
|
0.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
--
|
0.01
|
0.02
|
0.04
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.19
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
2.19
|
2.21
|
2.12
|
1.95
|
1.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
1.49
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
1.49
|
1.40
|
1.46
|
1.29
|
1.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-75.14
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-75.14
|
--
|
-20.97
|
-6.91
|
-26.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
15.09
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
15.09
|
14.75
|
16.46
|
15.59
|
17.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
1.17
--
Sales / Average Total Assets
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
1.17
|
0.98
|
0.71
|
0.62
|
0.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
52.17
--
Average Debtors / Sales * 365
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
52.17
|
58.16
|
61.80
|
58.94
|
53.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
143.86
--
Average Inventory / Sales * 365
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
143.86
|
166.14
|
141.90
|
118.47
|
121.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
81.46
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
81.46
|
96.25
|
95.70
|
76.04
|
57.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
114.57
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
114.57
|
128.04
|
107.99
|
101.37
|
116.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
EV/EBITDA
-286.51
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
May-26
|
May-25
|
May-24
|
May-23
|
May-22
|
|---|---|---|---|---|---|
|
AngioDynamics (ANGO)
|
-286.51
|
-26.32
|
11.63
|
1.64
|
0.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|